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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A150Figure 2. Primary human chondrocytes were pre-treated with inhibitors
for 30min and then treated with IL-1b/OSM overnight. Conditioned media
was immunoblotted for MMP-13. MMP-2 is shown as a loading control.
Experiment was repeated in 3 normal donors. Representative blots are
shown. PD98059: ERK inh. SP600125: JNK inh. SB203580: p38 inh. Rux-
olitinib: JAK1/2 inh.
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REDOX REGULATION OF CHONDROCYTE IGF-1 SIGNALING BY PKC-b1
V. Ulici y, D. Long z, R.F. Loeser, Jr. y. yUNC at Chapel Hill, Chapel Hill, NC,
USA; zWake Forrest Univ., Winston Salem, NC, USA
Purpose: Reactive oxygen species (ROS) can contribute to articular
cartilage degeneration in OA, but the mechanisms are incompletely
understood. IGF-1 signaling promotes chondrocyte matrix synthesis
and survival but is reduced in aging and OA. We have previously shown
that pathological levels of ROS activate chondrocyte MAP kinase sig-
naling and inhibit the IGF-1-IRS-1-PI3K-Akt pathway through phos-
phorylation of IRS-1 at inhibitory serine residues. In other tissues, PKC-
b1 activation by ROS was noted to serine phosphorylate IRS-1. In this
study, we investigated the role of PKC-b1 oxidation in regulating
chondrocyte IGF1 signaling under conditions of oxidative stress.
Methods: Primary human articular chondrocytes, isolated from normal
adult ankles, were treated for 30 mins. with 250mM tert-butyl hydro-
peroxide (tBHP) or 25mM menadione to induce oxidative stress. A PKC
general activator (PMA) and inhibitor (BIM) as well as a PKC-b speciﬁc
inhibitor (hispidin) were used to evaluate PKC regulation of IRS-1, ERK
MAP kinase and Akt phosphorylation, measured by immunoblotting.
PKC activation was measured by examining translocation from the
cytosol to the membrane by immunoblotting fractionated cell lysates.
PKC-b1 oxidation was evaluated by measuring cysteine sulfenic acid
formation using the reagent BCN-Bio1 which has a biotin tag allowing
for afﬁnity puriﬁcation of labelled proteins using streptavidin agarose
beads.
Results: Treatment of chondrocytes with PMA resulted in complete
inhibition of IGF1-induced phosphorylation of IRS-1 Tyr 612 (activating
site) as well as Akt phosphorylation and increased ERK and IRS-1 Ser
312 (inhibitory site) phosphorylation. The general PKC inhibitor BIM
blocked these effects conﬁrming they were due to PKC activation. ROS
induction using tBHP or menadione also activated ERK and decreased
IGF1 -induced IRS-1 Tyr 612 and p-Akt which was blocked by addition
of a PKC-b inhibitor. PKC-b1 translocated from the cytosol to the
membrane after treatment with menadione consistent with activation
by ROS (Fig.1A). A major mechanism for redox regulation of kinase
activity is through cysteine sulfenylation. We investigated this in
chondrocytes treated with menadione by afﬁnity labeling with BCN-
Bio1 which is speciﬁc for sulfenylation. PKC-b1 was pulled-down by
streptavidinwith the greatest amount seen after 30 mins. of menadione
treatment (Fig.1B).
Conclusions: These results support a role for PKC-b1 in the inhibition of
chondrocyte IGF-1 signaling under conditions of oxidative stress. Con-
sistent with our results, oxidation of PKC isoforms through cysteine
sulfenylation has been shown to promote their activity. Speciﬁc PKCs,
including PKC-b1, can serine phosphorylate IRS-1 resulting in inhibition
of downstream activation of Akt. Targeting the oxidative modiﬁcations
of PKC-b1 could serve as a novel means to restore the chondrocyte
response to IGF-1 in aging and OA.Fig.1. Oxidation of PKC-b1 in human chondrocytes treated with mena-
dione. (A) PKC-b1 translocation from the cytosol to the membrane. IGF-
1Rb (membrane) and LDH (cytosol) serve as fractionation controls. (B)
Pull-down of BCN-Bio1 tagged PKC-b1 using streptavidin. Levels of PKC-
b1 in the pre-pull down lysates shown as a control.
220
SUPERFICIAL ZONE CHONDROCYTES SECRETE A FACTOR THAT
REGULATES DEEP ZONE CARTILAGE MINERALIZATION BY
MODULATING POLYPHOSPHATE LEVELS
E. Delve, S. Bromand, J.-P. St-Pierre, M. Grynpas, R. Kandel. The
Lunenfeld-Tanenbaum Res. Inst., Toronto, ON, Canada
Purpose: Articular cartilage is an avascular tissue with a complex
depth-dependent zonal architecture with unique matrix composition
and organization, vital for maintaining joint function. Osteoarthritis
(OA) is a degenerative disease that disrupts this zonal arrangement and
manifests initially as loss of the superﬁcial zone (SZ) followed by pro-
gressive matrix loss and advancement of the calciﬁed zone into the
remaining articular cartilage region. We have shown previously that
polyphosphate, a naturally occurring linear polymer of phosphates, can
regulate mineralization in articular cartilage. The hypothesis of this
study is that superﬁcial zone cells modulate calciﬁcation of deep zone
cartilage (DZ) by modulating levels of cartilage polyphosphate levels
through a soluble factor.
Methods: Articular chondrocytes were isolated from either the SZ or DZ
of bovine cartilage obtained from the metacarpal-phalangeal joints (6-9
months). The cells were seeded individually on 3Dmembrane inserts in
conditions that favour formation of cartilage tissue and grown in side-
by-side co-culture for up to 7 days in mineralization inducing media
(MIM, b glycerophosphate). As a control DZ cells were grown in co-
culture with DZ cells. To determine if SZ cells were producing a soluble
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(SZ-CM) was collected daily and added to cultures of DZ cells to
determine its effect on mineralization. To examine the role of FGF sig-
nalling in regulating mineralization, DZ cells were treated with FGF-18
(10ng/mL), or CM supplemented with an FGF-receptor inhibitor
(PD173074 60nM) in MIM. Calcium and phosphate contents were
determined biochemically. Representative tissues were ﬁxed in for-
malin and embedded in parafﬁn. Sections were stained with Von kossa.
Polyphosphate (PP) was visualized by staining un-waxed histological
sections with DAPI, which shifts the emission spectra to the yellow-
green range when it binds to PP. PP was quantiﬁed following extraction
from the tissues by measurement of phosphate levels after alkaline
phosphatase digestion. A minimum of three independent experiments
were performed and each condition was done in duplicate or triplicate.
Results are expressed as mean ± standard error of the mean and ana-
lysed using a one-way analysis of variance followed by Tukey’s post hoc
test. Statistical signiﬁcance was assigned at p < 0.05.
Results: Side by side co-culture of DZ cells with SZ cells inhibited DZ
mineralization, compared to co-culture with DZ, as demonstrated by
signiﬁcantly decreased calcium and phosphate content and decreased
mineral deposits observed by Von Kossa staining. Treatment with SZ-
CM inhibited DZ mineralization, resulting in signiﬁcantly less calcium
and phosphate content compared to treatment with DZ-CM suggesting
that the cells were producing a soluble factor. SZ-CM was unable to
inhibit mineralization after heat treatment or trypsin digestion, sug-
gesting that the factor is a protein. Polyphosphate was present within
the matrix of tissue grown in non-mineralizing conditions, and staining
diminished in mineralized tissue. Polyphosphate levels were sig-
niﬁcantly higher in cartilage co-cultured with SZ cells, compared to DZ
cells. FGF-18 has been shown to attenuate hypertrophic differentiation
and we investigated whether this might be the factor responsible for
inﬂuencing mineralization. Treatment of DZ cells with FGF-18 mim-
icked the effects of the SZ-CM, with signiﬁcantly less mineralization and
more polyphosphate accumulation within the tissue. Furthermore,
treatment of DZ cells with SZ-CM in the presence of the FGF-receptor
inhibitor rescued mineralization, and signiﬁcantly reduced poly-
phosphate accumulation within cartilage formed by DZC.
Conclusions: SZ cells release a soluble factor, likely a protein as it is
sensitive to heat treatment and trypsin digestion, that inhibits miner-
alization of cartilage formed by DZ cells by up-regulating PP. Further
investigation is required to determine if SZ cells secrete a factor that
directly or indirectly, by up-regulating FGF-18 expression, inhibits
mineralization of cartilage formed by DZC, and whether a single factor
or combination of factors is required.
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CHONDROCYTE PHENOTYPE IS REGULATED BY ACTIN THROUGH
MRTF/SRF SIGNALING
J. Parreno, P.-H. Wu, R. Kandel. Lunenfeld-Tanenbaum Res. Inst., Toronto,
ON, Canada
Purpose: Chondrocytes that produce the appropriate cartilage matrix
are required for cell based repair of articular cartilage. Passaged
chondrocytes, a potential cell source for such applications, are FDA
approved and are favored over stem cell counterparts as they display
articular cartilage (interzone) progenitor characteristics and do not
readily undergo hypertrophy. However while culturing chondrocytes
in monolayer facilitates the proliferation necessary for cell number
expansion, it results in dedifferentiation, a process involving actin
stress ﬁbre formation. Actin can modulate gene expression through
myocardin related transcription factor (MRTF) and its association
with the serum response factor (SRF). Globular (g)-actin associates
with MRTF but this interaction is lost when actin polymerizes to
form ﬁlamentous (f)-actin. We previously showed that actin can
regulate MRTF and ﬁbroblast matrix gene expression in passaged
chondrocytes. The hypothesis of this study is that actin regulatory
pathways modulate chondrocyte dedifferentiation and that depoly-
merization contributes to redifferentiation.
Methods: Chondrocytes harvested from bovine articular cartilage
were expanded in 2D monolayer on polystyrene to obtain passage
two (P2) cells. To induce actin depolymerization, P2 cells were
treated with latrunculin B (LB). To probe MRTF or SRF generegulation, P2 cells were nucleofected with MRTF or SRF siRNA. To
induce redifferentiation, P2 chondrocytes were cultured in high
density 3D culture by seeding cells within 8mm diameter agarose
molds (4.0 x 10^4 cells/mm^2). Cells were maintained in rediffer-
entiation media (DMEM þ insulin-transferrin-selenium þ dex-
amethasone þ ascorbic acid) for up to 20 days.
Actin organization and MRTF localization was visualized through
immunocytochemical staining and confocal microscopy. For protein
isolation, total protein was harvested by RIPA extraction, G- to f-actin
separation was performed through differential triton solubility, and
cytoplasmic and nuclear portions were separated using NE-PER reagent
kit. Protein analysis was performed using Western Blots followed by
densitometry. RNAwas extracted using TRIzol and gene expression was
examined using qRT-PCR and gene speciﬁc primers. 3-4 independent
experiments were performed in at least triplicate. Statistical compar-
isonswere assessed using a student t-test or ANOVA followed by tukey’s
post-hoc.
Results: Compared to primary (P0), P2 cells had decreased expres-
sion of chondrogenic (sox9, aggrecan (acan), collagen 2 (col2) but
increased expression of proliferation marker cyclin D1 (ccnd1),
ﬁbroblast matrix (collagen type 1 (col1), tenascin c (tnc)) and con-
tractile (alpha smooth muscle actin (asma) and transgelin (tagln))
gene levels. Passaging resulted in a steady increase in total actin,
actin polymerization, and MRTF nuclear localization over time. Actin
depolymerization by LB resulted in cytoplasmic MRTF localization. LB
also reduced ccnd1, col1, asma, tagln and col2 but elevated sox9 and
acan gene levels. MRTF knockdown repressed col1, tnc, asma, tagln
and col2, increased sox9 and acan, and had no effect on ccnd1. SRF
knockdown had similar effects to MRTF knockdown but col1 and
col2 expression was not affected suggesting that MRTF may regulate
these genes independent of SRF. Culture of cells in 3D led to actin
depolymerisation and mimicked the effect LB had on cells in 2D
culture. The effects of 3D culture were apparent within 2 days.
Although 3D culture initially decreased col2 by 2 days, which does
not favor redifferentiation, col2 steadily increased from day 2 to 20.
After 20 days of 3D culture cells were positive for col2 and aggrecan
but not col1.
Conclusions: Monolayer culture results in actin polymerization that
leads to dedifferentiation as it promotes proliferation, ﬁbroblast matrix,
and contractile gene expression and suppresses chondrogenic gene
expression. Our data suggests that regulation of this process is complex
but involves the MRTFa- SRF signalling pathway. Actin depolymerisa-
tion and reversal of this signalling mediates redifferentiation of pas-
saged cells. Understanding the regulation of redifferentiation could lead
to the use of articular chondrocytes as a cell source to repair damaged
articular cartilage.
Figure 1. Proposed mechanism for actin regulation of gene expression in
passaged chondrocytes. ‘?’ indicates signalling pathway not yet identiﬁed.
